# PET/MRI to Stage Prostate Cancer Patients

> **NCT06484361** · PHASE2 · RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 50 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 68Ga-PSMA
- **DRUG:** 68Ga-RM2

## Key facts

- **NCT ID:** NCT06484361
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-09-09
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06484361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06484361, "PET/MRI to Stage Prostate Cancer Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06484361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*